Loading clinical trials...
Loading clinical trials...
The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Palpebral Fissure Height, Eye Redness, and Patient-reported Eye Appearance
Conditions
Interventions
Oxymetazoline hydrochloride 0.1% ophthalmic solution
Placebo
Locations
1
United States
University of Miami Bascom Palmer Eye Institute
Miami, Florida, United States
Start Date
June 8, 2021
Primary Completion Date
April 1, 2022
Completion Date
April 1, 2022
Last Updated
April 24, 2023
Lead Sponsor
University of Miami
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions